
PEN (rat)
CAS No. 569364-13-2
PEN (rat)( —— )
Catalog No. M30583 CAS No. 569364-13-2
Endogenous peptide GPR83 agonist. ProSAAS-derived neuropeptide.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePEN (rat)
-
NoteResearch use only, not for human use.
-
Brief DescriptionEndogenous peptide GPR83 agonist. ProSAAS-derived neuropeptide.
-
DescriptionEndogenous peptide GPR83 agonist. ProSAAS-derived neuropeptide.
-
In VitroMouse PEN (mPEN) and rat PEN (rPEN) only differ by one residue at the N-terminal end, whereas human PEN (hPEN) is more divergent and has the sequence PEG instead of PEN.PEN binds and activates a GPCR in the brain.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetGRK (GPCRK)
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number569364-13-2
-
Formula Weight2301.62
-
Molecular FormulaC102H169N27O33
-
Purity>98% (HPLC)
-
SolubilityPBS (pH 7.4):1 mg/mL
-
SMILES[H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gomes et al (2016) Identification of GPR83 as the receptor for the neuroendocrine peptide PEN. Sci.Signal. 9 ra43 PMID:
molnova catalog



related products
-
Compound 101
Compound 101 (GRK2 inhibitor 101, Takeda compound 101, Cmpd101)?is a novel membrane-permeable, small-molecule inhibitor of GRK2 and GRK3.
-
GRK6-IN-1
GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with an IC50 of 120 nM, and has potential for study in multiple myeloma.
-
GSK270822A
GSK270822A is a selective ROCK1 inhibitor. GSK270822A exhibits IC50 of 9nM, 1100nM, 1550nM for ROCK1, RSK1, p70S6K, respectively.